Premarket Losers

CEMTREX TO HOST FISCAL THIRD QUARTER 2024 FINANCIAL RESULTS CONFERENCE CALL ON WEDNESDAY, AUGUST 14, 2024 AT 5:00 P.M. EASTERN TIME

News

hauppauge, ny, aug. 09, 2024 (globe newswire) -- - cemtrex inc. (nasdaq: cetx, cetxp), an advanced security technology and industrial services company, will hold a conference call on wednesday, august 14, 2024 at 5:00 p.m. eastern time to discuss its results for the fiscal third quarter ended june 30, 2024. a press release detailing these results will be issued prior to the call.

AVINGER ANNOUNCES ISSUANCE OF NEW U.S. PATENT AND RECEIVES NOTICES OF ALLOWANCE FOR FIVE ADDITIONAL U.S. PATENTS

News

redwood city, ca / accesswire / september 18, 2024 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the issuance of a new u.s. patent and the allowance of five additional u.s. patents that are expected to issue over the next four months. these patents expand intellectual property protection for avinger's proprietary image-guided system and devices for both peripheral and coronary applications.

AGEAGLE AERIAL SYSTEMS INC. ANNOUNCES REVERSE STOCK SPLIT

News

wichita, kansas, oct. 03, 2024 (globe newswire) -- ageagle aerial systems inc. (nyse american: uavs) (“ageagle” or the “company”), an industry-leading provider of full stack flight hardware, sensors and software for commercial and government use, announced today a reverse stock split of its authorized, issued and outstanding common stock, par value $0.001 per share, at a ratio of one (1) share of common stock for every fifty (50) shares of common stock, effective as of 5:00 p.m. (eastern time) on october 14, 2024 (the “effective date”). the company's common stock will begin trading on a split-adjusted basis when the market opens on october 15, 2024. the reverse stock split was authorized by the company's board of directors on october 3, 2024. pursuant to the laws of the state of nevada, the company's state of incorporation, the company's board of directors has the authority to effect a reverse stock split without shareholder approval if the number of authorized shares of common stock and the number of outstanding shares of common stock are proportionally reduced. the company will file a certificate of change to its articles of incorporation, as amended, with the secretary of state of nevada to effect the reverse stock split. the company's common stock will continue to trade on the nyse american under the stock ticker “uavs” but will trade under the new cusip number 00848k 309.

IDEAYA BIOSCIENCES ANNOUNCES LATE-BREAKER ORAL PRESENTATION OF IDE397 PHASE 1 EXPANSION RESULTS IN MTAP-DELETION LUNG AND UROTHELIAL CANCER AT THE 36TH EDITION OF THE EORTC-NCI-AACR SYMPOSIUM

News

south san francisco, calif. , oct. 4, 2024 /prnewswire/ -- ideaya biosciences, inc. (nasdaq:idya), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced a late-breaking oral presentation of the phase 1 expansion results of ide397, a first-in-class, oral, mat2a inhibitor in methylthioadenosine phosphorylase (mtap)-deletion urothelial and non-small cell lung cancer (nsclc) patients at the 36th edition of the eortc-nci-aacr symposium on molecular targets and cancer therapeutics taking place on october 23 to 25, 2024, in barcelona, spain.

REPEAT: ELEVAI BIOSCIENCES, A SUBSIDIARY OF ELEVAI LABS INC., EXPANDS PATENT PORTFOLIO WITH TWO NEW FILINGS FOR EL-22 IN MUSCLE LOSS TREATMENT FOR OBESE PATIENTS, INCLUDING GLP-1 RECEPTOR AGONIST COMBINATIONS

News

elevai biosciences, a subsidiary of elevai labs inc., expands patent portfolio with two new filings for el-22 in muscle loss treatment for obese patients,

RENOVAROCUBE TO PRESENT CUTTING-EDGE CANCER DIAGNOSTICS RESEARCH AT EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY CONGRESS

News

amsterdam, sept. 13, 2024 (globe newswire) -- (nasdaq: renb) renovarocube (cube, the company), a leading ai-driven innovator using multi-omics technology for cancer profiling, is pleased to announce two scientific presentations at a leading cancer conference – the european society for medical oncology (esmo) congress – on september 15, 2024.

COLOR STAR TECHNOLOGY REGAINS COMPLIANCE WITH NASDAQ MINIMUM CLOSING BID PRICE RULE

News

new york, oct. 01, 2024 (globe newswire) --  color star technology co., ltd. (nasdaq: add) (“color star” or the “company”), an entertainment technology company with a global network that focuses on the application of technology and artificial intelligence in the entertainment industry, announced today that it received a formal notification from the nasdaq stock market llc (“nasdaq”) that the company has regained compliance with nasdaq listing rule 5550(a)(2), which requires the company's ordinary shares to maintain a minimum bid price of $1.00 per share.

THERIVA BIOLOGICS ANNOUNCES PRICING OF $2.5 MILLION PUBLIC OFFERING

News

rockville, md., sept. 26, 2024 (globe newswire) -- theriva biologics, inc. (nyse american: tovx) (“theriva” or the “company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced the pricing of its “reasonable best efforts” public offering for the purchase and sale of up to 1,428,600 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 1,428,600 shares of common stock at a combined offering price of $1.75 per share and accompanying warrant (the “offering”). the company expects to receive aggregate gross proceeds of approximately $2.5 million, before deducting placement agent fees and other offering expenses, and assuming no exercise of the warrants. the warrants will have an exercise price of $2.00 per share, will be exercisable immediately and will expire five years from the issuance date.

KAIXIN HOLDINGS ANNOUNCES EXTRAORDINARY GENERAL MEETING RESULTS

News

hangzhou, china, oct. 03, 2024 (globe newswire) -- kaixin holdings (“kaixin” or the “company”) (nasdaq: kxin) today announced that all resolutions presented to the shareholders at its extraordinary general meeting held on october 1, 2024 (the “extraordinary general meeting”) were duly passed.

ICORECONNECT INC. ANNOUNCES STRATEGIC ACQUISITION OF HEALTHCARE CIRCLE OF EXCELLENCE ASSETS

News

ocoee, fla., oct. 03, 2024 (globe newswire) -- icoreconnect inc. (nasdaq: icct), a prominent cloud-based software and technology provider dedicated to enhancing workflow efficiency and profitability through its enterprise and healthcare platform, today announced the acquisition of substantially all of the assets of the healthcare circle of excellence (hcofe). this acquisition positions icoreconnect as a leader in providing essential resources and solutions to help local healthcare community partners and practices remain independent and thrive.

ALLERGAN AESTHETICS AND GIRLS INC. CELEBRATE SIX YEARS AND CHALLENGE YOU TO TAKE THE PLEDGE TO SUPPORT MENTORSHIP IN STEM

News

-- live panel discussion at the girls inc. be bold leadhers summit at houston community college with expert women healthcare providers irvine, calif. , oct. 4, 2024 /prnewswire/ -- today allergan aesthetics, an abbvie company, announces the sixth consecutive year of partnership with girls inc. the partnership supports high school and college girls' interest in stem and mentorship.

BIOCARDIA REGAINS FULL COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS

News

sunnyvale, calif., sept. 18, 2024 (globe newswire) -- biocardia, inc. [nasdaq: bcda], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that the company has regained full compliance with the nasdaq capital market's listing requirements as required by the hearing panel's (the “panel”) decision on may 13, 2024.

PINEAPPLE ENERGY ANNOUNCES RESTRUCTURING OF EXISTING SERIES A CONVERTIBLE PREFERRED STOCK AND RELATED WARRANTS

News

pineapple energy inc. is announcing that they have entered into securities exchange agreements with the holders of the company' series a preferred stock.

SMITH MICRO COMPLETES CONCURRENT EQUITY OFFERINGS RAISING $6.9 MILLION

News

pittsburgh--(business wire)--smith micro software, inc. (the “company” or “smith micro”) (nasdaq: smsi) today announced the completion of investments in company securities in two offerings: a registered offering with certain institutional and accredited investors and an unregistered offering with the company's chief executive officer. both offerings were priced based on the market value of the offered securities as of the time of signing the purchase agreements, and the gross proceeds of the tw.

INDIA, ITALY AND AUSTRALIA: SOBRSAFE PROVIDES INTERNATIONAL UPDATE

News

critical infrastructure, commercial fleets and family law highlight new global applications denver, co / accesswire / october 3, 2024 / sobr safe, inc. (nasdaq:sobr) ("sobrsafe"), provider of next-generation transdermal alcohol detection solutions, today provided an update on the opportunity for international expansion across three foundational markets. in each case below, sobrsafe was approached by the interested party to engage our technologies.

EQUILLIUM ANNOUNCES SECOND QUARTER 2024 ESTIMATED CASH AND INVESTMENTS BALANCE

News

la jolla, calif.--(business wire)---- $eq #gvhd--equillium, inc. (nasdaq: eq), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced second quarter 2024 estimated ending cash, cash equivalents and short-term investments of approximately $33.3 million, representing an increase of approximately $1.0 million from the end of the first quarter of 2024. the increase is primarily the result of receiving a tax credit of.

RENEO PHARMACEUTICALS ANNOUNCES STOCKHOLDER APPROVAL OF MERGER WITH ONKURE

News

– combined company to trade on nasdaq under ticker “okur” – reneo announces 1-for-10 reverse split of common stock irvine, calif., oct. 02, 2024 (globe newswire) -- reneo pharmaceuticals, inc. (nasdaq: rphm) (“reneo”) today announced the results of the special meeting of its stockholders held on september 26, 2024.

HWH INTERNATIONAL INC. ENTERS INTO A JOINT VENTURE TO BUILD ITS TRAVEL BUSINESS IN ASIA

News

bethesda, md, april 26, 2024 (globe newswire) -- hwh international inc. (“hwh”) (nasdaq: hwh) announced today that it has entered into a joint venture through its subsidiary health wealth happiness pte ltd. (“hwhpl”), with mr. chen ziping (“mr. chen”), an experienced entrepreneur in the travel industry, and mr. chan heng fai ambrose, hwh's executive chairman (“mr. chan”). this new joint venture is part of hwh's strategy of building its travel business in asia.

N2OFF INC. AND SOLTERRA UNLOCK NEW POTENTIAL FOR CAPACITY EXPANSION IN SOLAR PV PROJECT

News

solterra's review reveals a 10% capacity increase, exceeding initial expectations and opening new opportunities for growth

J-LONG GROUP LIMITED RECEIVES NASDAQ DEFICIENCY NOTICE REGARDING MINIMUM BID PRICE REQUIREMENT

News

ordinary shares will continue to trade on the nasdaq global market, and the company's listing on such exchange is not affected by the receipt of the notice

CORRECTION: ONCONETIX ANNOUNCES FINANCING THROUGH A $2.0 MILLION PRIVATE PLACEMENT OF SERIES C PREFERRED STOCK AND WARRANTS, ESTABLISHES A $25 MILLION EQUITY LINE OF CREDIT

News

cincinatti, oh., oct. 03, 2024 (globe newswire) -- in a release issued under the same headline earlier today by onconetix, inc. (nasdaq: onco), please note that in the first paragraph of the release, the name of the financial advisor to onconetix in the transaction had been corrected to tungsten advisors. the corrected release follows.

MICROALGO INC. (NASDAQ: MLGO) ANNOUNCED TO JOINTLY ESTABLISH A MICRO-CONSCIOUSNESS QUANTUM RESEARCH CENTER WITH WIMI (NASDAQ: WIMI)

News

beijing , june 4, 2024 /prnewswire/ -- microalgo inc. (nasdaq: mlgo) (the "company" or "microalgo"), today announced that microalgo and wimi will jointly establish a micro-consciousness quantum research center. it will integrate physics, mathematics, medicine, genetics, computer science, biology, polymer chemistry, philosophy, psychology, sociology, and many other disciplines to form a comprehensive research institute based on various disciplines centered on consciousness.

PROCESSA PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF NGC-CAP IN METASTATIC BREAST CANCER

News

hanover, md., oct. 02, 2024 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) (processa or the company), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced that the first patient has been dosed in a phase 2 clinical trial evaluating ngc-cap for the treatment of advanced or metastatic breast cancer.

VIVOPOWER'S TEMBO ANNOUNCES DEFINITIVE AGREEMENT WITH PRE-EMINENT JEEPNEY GROUP, SARAO MOTORS, IN THE PHILIPPINES' ESTIMATED US$10BN JEEPNEY MARKET

News

iconic jeepneys are the main form of public transport in the philippines, with over 200,000 in service jeepneys account for approximately one-third of carbon emissions in the country established in 1953, sarao motors is the philippines' pre-eminent jeepney group sarao motors selected tembo to be its exclusive partner to provide electric jeepneys tembo will continue to be able to work with other companies to provide electric jeepney solutions london, oct. 03, 2024 (globe newswire) -- tembo e-lv b.v. (“tembo”), a subsidiary of nasdaq-listed b corporation, vivopower international plc (nasdaq: vvpr) (“vivopower”), is very pleased to announce its definitive partnership agreement with the iconic philippine jeepney manufacturer sarao motors (“sarao”).

LOGICMARK, INC. ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS; EXPANSION STRATEGY INTO PERSONAL SAFETY MARKETS CONTINUES

News

louisville, ky., aug. 13, 2024 (globe newswire) -- logicmark, inc. (nasdaq: lgmk), a provider of personal safety, personal emergency response systems (pers), health communications devices, and technology for the growing care and safety economy, today announced financial results for the quarter ended june 30, 2024.

KAIVAL BRANDS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES MERGER OF KAIVAL BRANDS INNOVATIONS GROUP, INC. - KAVL

News

new orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed merger of kaival brands innovations group, inc. (the “company”) (nasdaqcm: kavl) and delta corp holdings limited. pursuant to the terms of the agreement, shareholders of kaival brands will receive 1 ordinary share of a specially created holding company incorporated under the laws of the cayman islands, delta corp hold.

AMERICAN REBEL HOLDINGS, INC. SHIPS RE-STOCKING ORDER FROM KANSAS' STANDARD BEVERAGE FOR AMERICAN REBEL LIGHT BEER

News

nashville, tn, oct. 02, 2024 (globe newswire) -- american rebel holdings, inc. (nasdaq: areb) ("american rebel" or the "company"), the creator of american rebel beer (www.americanrebelbeer.com), and branded safes, personal security and self-defense products and apparel, announced their operating subsidiary american rebel beverages, llc received a multi-pallet re-stocking order for 12-packs of 12oz cans from kansas' standard beverage.

ROSEN, LEADING INVESTOR COUNSEL, ENCOURAGES SAGE THERAPEUTICS, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION – SAGE

News

new york, oct. 03, 2024 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of sage therapeutics, inc. (nasdaq: sage) between april 12, 2021 and july 23, 2024, both dates inclusive (the “class period”), of the important october 28, 2024 lead plaintiff deadline.

JACKIE MCKINLEY JOINS PEGA TO DRIVE AMERICAS ENTERPRISE SALES AND CLIENT SUCCESS

News

cambridge, mass.--(business wire)--pegasystems inc. (nasdaq: pega), the leading enterprise ai decisioning and workflow automation platform provider, today announced it has appointed jackie mckinley as head of americas commercial sales. an accomplished sales leader and strategist, ms. mckinley will oversee the execution of pega's sales strategy and relationship management for all commercial clients in the americas. ms. mckinley joins pega with more than 30 years of global sales and executive man.

MAISON SOLUTIONS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

News

monterey park, ca / accesswire / september 23, 2024 / maison solutions inc. (nasdaq:mss) ("maison solutions" or the "company"), a u.s.-based specialty grocery retailer offering traditional asian and international food and merchandise, today announced financial results for the first quarter ended july 31, 2024. management commentary "we are pleased with our financial results for q1 2025, as it marked the first full quarter with lee lee included under the maison solutions umbrella," said john xu, president, chairman and chief executive officer of maison solutions.

BANZAI GRANTED EXTENSION BY NASDAQ HEARING PANEL TO REGAIN COMPLIANCE WITH CONTINUED LISTING REQUIREMENTS

News

seattle, oct. 02, 2024 (globe newswire) -- banzai international, inc. (nasdaq: bnzi) (“banzai” or the “company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it received notice from the nasdaq listing qualifications panel (the “hearings panel”) of the nasdaq stock market llc (“nasdaq”) that the hearings panel has granted the company's request to continue its listing on the nasdaq stock market, subject to the company meeting certain conditions, including filing on or before october 7, 2024, an application for listing on the nasdaq capital market, and demonstrating compliance on or before january 31, 2025 with listing rules 5550(a)(2), 5550(a)(5) and 5550(b)(1). the company is in violation of the bid price requirement of nasdaq listing rule 5450(a)(1) (the “bid price rule”) and the market value of listed securities (“mvls”) requirement in listing rule 5450(b)(2)(a) (the “mvls rule”).

LASER PHOTONICS AND FONON TECHNOLOGIES RECEIVE ORDER THROUGH ADS FOR MARINE AVIATION LOGISTICS SQUADRON

News

orlando, fla.--(business wire)--laser photonics corporation (lpc) (nasdaq: lase), a leading global developer of industrial laser systems for cleaning and other material processing applications, in partnership with fonon technologies, announced today that it has received an order for the dtmr-3040 laser cleaning system through ads, a military equipment and logistics powerhouse, for a california-based marine corps aviation logistics squadron (mals). the defensetech mrls roughening laser (dtmr-304.

PSYENCE GROUP ENTERS INTO AGREEMENT TO DISPOSE OF STAKE IN PSYLABS

News

psylabs develops and produces certified pharmaceutical-grade natural psychedelics for applications in mental health and well-being psylabs develops and produces certified pharmaceutical-grade natural psychedelics for applications in mental health and well-being

PROFESSIONAL DIVERSITY NETWORK, INC. ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2024

News

chicago, aug. 13, 2024 (globe newswire) -- professional diversity network, inc. (nasdaq:ipdn), (“ipdn” or the “company”), a global developer and operator of online and in-person networks that provides access to networking, training, educational and employment opportunities for diverse individuals, today announced its financial results for the quarter ended june 30, 2024.

INSPIRE VETERINARY PARTNERS ANNOUNCES NON-BINDING ACQUISITION PROPOSAL OF VETSIE.AI

News

virginia beach, va / accesswire / august 27, 2024 / inspire veterinary partners, inc. (nasdaq:ivp) ("inspire" or the "company"), an owner and provider of pet health care services throughout the u.s., today announced that it has entered into a non-binding letter of intent (the "loi") with vetsie.ai, an artificial intelligence ("ai") software platform designed to empower veterinary professionals with quick, accurate access to critical information on patient conditions, treatments, and medications, to engage in diligence and initial negotiations regarding the terms of a potential transaction whereby inspire may acquire vetsie.ai in an all- stock transaction. this potential equity-only acquisition, if consummated, would be completed without the need for any operating capital infusion from inspire into the acquired business for the first fiscal year.

ATOSSA THERAPEUTICS COMMEMORATES BREAST CANCER AWARENESS MONTH, HIGHLIGHTING THE NEED FOR INNOVATION ACROSS THE BREAST CANCER TREATMENT CONTINUUM

News

seattle, oct. 01, 2024 (globe newswire) -- atossa therapeutics, inc. (nasdaq: atos) ("atossa" or the "company"), today announced its recognition and support of breast cancer awareness month this october; highlighting the importance of increasing awareness, advancing research, and driving progress toward innovative treatments for breast cancer. approximately one in eight women will be diagnosed with breast cancer in their lifetime, so this annual campaign serves as a powerful reminder of the ongoing need for education, early detection, prevention, and access to effective treatment options. atossa therapeutics is a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer.

SFL - SUCCESSFUL PLACEMENT OF FIVE YEAR SENIOR UNSECURED BONDS

News

sfl corporation ltd. (nyse: sfl) (the "company" or "sfl") today successfully placed nok 750 million senior unsecured bonds due september 25, 2029. the bonds will pay a quarterly coupon of the 3 month norwegian interbank offered rate (nibor) + 3.25 % per annum.

BIOATLA ANNOUNCES UPCOMING POSTER PRESENTATION AT THE 39TH SOCIETY FOR IMMUNOTHERAPY OF CANCER ANNUAL MEETING

News

san diego, oct. 04, 2024 (globe newswire) -- bioatla, inc. (nasdaq: bcab), a global clinical-stage biotechnology company focused on the development of conditionally active biologic (cab) antibody therapeutics for the treatment of solid tumors, today announced a poster presentation at the upcoming 39th society for immunotherapy of cancer (sitc) annual meeting, being held from november 8–10, 2024 at the george r. brown convention center in houston, tx.

IMMUNEERING ANNOUNCES POSITIVE INITIAL PHASE 2A DATA INCLUDING COMPLETE AND PARTIAL RESPONSES WITH IMM-1-104 IN COMBINATION WITH CHEMOTHERAPY IN FIRST-LINE PANCREATIC CANCER PATIENTS

News

immuneering announces positive initial phase 2a data including complete and partial responses with imm-1-104 in combination with chemotherapy in first-line

CPS HR CONSULTING PARTNERS WITH GOVINVEST TO REVOLUTIONIZE COMPENSATION CONSULTING WITH ADVANCED TECHNOLOGY

News

sacramento, calif.--(business wire)--cps hr consulting, a leader in public sector hr consulting, is thrilled to announce a strategic partnership with govinvest, the pioneer of compensation analytics technology for government agencies. this collaboration aims to combine cps hr's renowned compensation consulting expertise with govinvest's innovative software platform, offering unparalleled data confidence and decision-making capabilities. highlights of the partnership best-in-class consulting + t.

CUE BIOPHARMA ANNOUNCES UPCOMING SCIENTIFIC PRESENTATIONS AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER'S (SITC) 39TH ANNUAL MEETING

News

boston, oct. 04, 2024 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific t cells, today announced it will deliver an oral and a poster presentation on the company's immuno-stat™ clinical assets cue-101 and cue-102, representative of the cue-100 series, at the society for immunotherapy of cancer's 39th annual meeting (sitc 2024). the conference will be held in houston, texas, on november 6-10, 2024.

VS MEDIA HOLDINGS LIMITED REGAINS COMPLIANCE WITH NASDAQ MINIMUM CLOSING BID PRICE REQUIREMENT

News

hong kong, july 05, 2024 (globe newswire) --  vs media holdings limited (nasdaq: vsme , the "company"), a leader in managing a global network of digital creators, today announced the receipt of formal notice from the nasdaq stock market llc ("nasdaq") that the company has regained compliance with the minimum bid price requirement set forth in nasdaq listing rule 5550(a)(2).

LIGHTPATH DEPLOYS INDUSTRY'S FIRST 400G PROTECTED CIRCUIT UTILIZING POWER-EFFICIENT CIENA WAVELOGIC 5 NANO COHERENT OPTICS

News

raises ceiling for high-availability network services while using 80% less power new york , sept. 25, 2024 /prnewswire/ -- lightpath , an all-fiber, infrastructure-based connectivity provider that is revolutionizing how organizations connect to their digital destinations, and  ciena (nyse: cien), a global leader in networking systems, services, and software, recently deployed the industry's first known 400 gb/s protected optical circuit utilizing power-efficient and high-performance pluggable technologies.

TREASURE GLOBAL INC ANNOUNCES TERMINATION OF ITS AT-THE-MARKET OFFERING PROGRAM

News

new york and kuala lumpur, malaysia, oct. 01, 2024 (globe newswire) -- treasure global inc (nasdaq: tgl) (“treasure global” or the “company”), a leading technology solutions provider, is pleased to announce that it has completed its previously disclosed at-the-market equity offering program (“atm offering”) launched on march 22, 2024, and the termination of the same with h.c. wainwright & co., llc, as sales agent on september 25, 2024.

BOWMAN CONTRACTED BY ILLINOIS DEPARTMENT OF TRANSPORTATION FOR I-55 CORRIDOR REHABILITATION PROJECT

News

reston, va.--(business wire)-- #betterwithbowman--bowman consulting group ltd. (the company or bowman) (nasdaq: bwmn), a national engineering services firm delivering infrastructure design solutions and project management services to customers who own, develop and maintain the built environment, has been contracted by the illinois department of transportation (idot) to provide corridor management and design services for a 15.6-mile corridor of i-55. “we are excited to start working on the highly impactful and inno.

GROVE COLLABORATIVE ANNOUNCES $15M PIPE INVESTMENT FROM VOLITION CAPITAL

News

san francisco--(business wire)---- $grov--grove collaborative announces $15m pipe investment from volition capital.

SIGA TECHNOLOGIES (SIGA) SHARES TUMBLE AFTER MPOX THERAPY FAILS, CHIEF MEDICAL OFFICER TERMINATED - HAGENS BERMAN

News

san francisco, oct. 03, 2024 (globe newswire) -- biopharmaceutical company siga technologies is under intense scrutiny over its prior disclosures regarding the potential expansion of its lead product, tpoxx®, to treat mpox.

SILEXION THERAPEUTICS REPORTS BREAKTHROUGHS FROM SIL-204 PRECLINICAL STUDIES

News

grand cayman, cayman island--(business wire)---- $slxn #biotech--silexion therapeutics corp. (nasdaq: slxn) (“silexion” or the “company”), a clinical-stage biotech developing rna interference (rnai) therapies for kras-driven cancers, today announced new preclinical findings for sil-204, its second-generation sirna candidate, following the optimization of its extended-release formulation. these latest findings demonstrate that the latest sil-204-microparticle formulation can inhibit the growth and induce necrosis.

TRUST STAMP ANNOUNCES PRICING OF REGISTERED DIRECT OFFERING AND WARRANT INDUCEMENT, PRICED AT-THE-MARKET, FOR AGGREGATE GROSS PROCEEDS OF $2.0 MILLION

News

atlanta, ga, sept. 03, 2024 (globe newswire) -- trust stamp (nasdaq: idai), the privacy-first identity company™ providing ai-powered software used globally across multiple sectors, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 1,432,399 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering priced at-the-market under nasdaq rules. in a concurrent private placement, the company also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 2,864,798 shares of common stock. the combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant is $0.3223. the private placement warrants will be exercisable upon receipt of shareholder approval, will expire five years from the initial exercise date and will have an exercise price of $0.3223 per share.

COHERUS TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 8, 2024

News

redwood city, calif., aug. 01, 2024 (globe newswire) -- coherus biosciences, inc. (“coherus,” nasdaq: chrs) today announced that its second quarter 2024 financial results will be released after market close on thursday, august 8, 2024. starting at 5:00 p.m. edt on august 8, 2024, coherus' management team will host a conference call and webcast to discuss financial results and provide a general business update.

CANOO'S OKLAHOMA CITY MANUFACTURING FACILITY ACHIEVES FINAL ACTIVATION AS FIRST AUTOMOTIVE FOREIGN-TRADE ZONE IN THE STATE OF OKLAHOMA

News

ftz activation insulates canoo from import tariffs and allows for deferments and exemptions as the company expands its global presence the approval of canoo's ftz allows other vendors and partners to relocate into canoo's user-driven site thereby broadening the benefits to canoo and its partners effective immediately providing a 5% reduction in bom costs for imported parts significantly improving margins justin, texas, sept. 19, 2024 (globe newswire) --  canoo inc. (nasdaq: goev), a high-tech advanced mobility company, announced today that the u.s. customs and border protection (cbp) has officially approved final activation of canoo's oklahoma city operations as a foreign-trade zone (ftz), becoming one of the largest ftzs in the state of oklahoma.

TRANSDIGM GROUP DECLARES A SPECIAL CASH DIVIDEND OF $75.00 PER SHARE AND ANNOUNCES SUCCESSFUL COMPLETION OF INCREMENTAL DEBT

News

cleveland , sept. 20, 2024 /prnewswire/ -- transdigm group incorporated ("transdigm group") (nyse: tdg) today announced that its board of directors has authorized and declared a special cash dividend of $75.00 on each outstanding share of common stock and cash dividend equivalent payments on eligible vested options granted under its stock option plans.

GREENWAVE TECHNOLOGY SOLUTIONS' SCRAP APP SETS NEW WEEKLY REVENUE RECORD; EXPANDS TO GREENVILLE, NC MARKET

News

company launches trust pilot reviews  to boost google search ranking and optimize its conversion rate scrapapp.com  is capturing market share and growing revenue in key markets primarily utilizing cashflows generated from operating activities chesapeake, va. , aug. 2, 2024 /prnewswire/ -- greenwave technology solutions, inc. ("greenwave" or the "company") (nasdaq: gwav), an operator of metal recycling facilities in virginia, north carolina, and ohio, announced today that its wholly-owned subsidiary, scrap app, inc., set a new weekly revenue record from cars purchased through the scrapapp.com platform from july 21 through and including july 27, 2024.

ADDENTAX GROUP CORP. ANNOUNCES PRIVATE PLACEMENTS OF ITS COMMON STOCK

News

shenzhen, china , april 29, 2024 /prnewswire/ -- addentax group corp. ("addentax" or the "company") (nasdaq: atxg), an integrated service provider focusing on garment manufacturing, logistics services, property management, and subleasing, has announced that it has entered into private placement agreements (the "agreements") with two investors (the "investors"), who are independent third parties. under the agreements, the company will sell to each of the investor 330,000 shares of common stock at a purchase price of $0.98 per share, resulting in aggregate gross proceeds of $646,800.

LE MANS ULTIMATE RELEASES INNOVATIVE CO-OP GAME MODE, SAVE & LOAD SYSTEM AND 2024 PACK 2 DLC

News

miami, sept. 24, 2024 (globe newswire) -- motorsport games inc. (nasdaq: msgm) (“motorsport games” or “the company”) has released the september update for “le mans ultimate”, the official game of the fia world endurance championship and the 24 hours of le mans. this latest update, available now, includes a new co-op game mode, a completed hypercar grid, and the release of iconic new content for fans of sportscar and sim racing.

NURIX THERAPEUTICS ANNOUNCES PRESENTATIONS AT DISCOVERY ON TARGET CONFERENCE

News

san francisco, sept. 30, 2024 (globe newswire) -- nurix therapeutics, inc. (nasdaq: nrix), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced three oral presentations at the 22nd annual discovery on target conference, being held september 30 – october 3, 2024, in boston, ma.

C3IS INC. REPORTS SECOND QUARTER AND SIX MONTHS 2024 FINANCIAL AND OPERATING RESULTS

News

athens, greece, aug. 22, 2024 (globe newswire) -- c3is inc. (nasdaq: ciss) (the “company”), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the second quarter and six months ended june 30, 2024.

NISUN INTERNATIONAL TO ANNOUNCE H1 2024 FINANCIAL RESULTS BY OCTOBER 15, 2024, AND HOST FIRST INVESTOR CONFERENCE CALL

News

shanghai , sept. 23, 2024 /prnewswire/ -- nisun international enterprise development group co., ltd.

EVERQUOTE ANNOUNCES RECORD SECOND QUARTER 2024 FINANCIAL RESULTS

News

cambridge, mass., aug. 05, 2024 (globe newswire) -- everquote, inc. (nasdaq: ever), a leading online insurance marketplace, today announced financial results for the second quarter ended june 30, 2024.

VERTEX ENERGY AND ITS LENDERS INITIATE FORMAL PATHWAY AIMED AT ACHIEVING SUSTAINABLE CAPITAL STRUCTURE

News

houston--(business wire)--vertex energy, inc. (nasdaq: vtnr) ("vertex" or the "company"), a leading specialty refiner and marketer of high-quality refined products, today announced it entered into a restructuring support agreement (the “rsa”) with overwhelming support of 100% of the company's term loan lenders (the “consenting term loan lenders”). to facilitate the transactions contemplated under the rsa, including exploration of a sale transaction, the company commenced chapter 11 cases in the.

GLADSTONE INVESTMENT ANNOUNCES UPDATED PAYMENT DATE FOR $0.70 SUPPLEMENTAL DISTRIBUTION TO COMMON STOCKHOLDERS

News

mclean, va / accesswire / september 26, 2024 / gladstone investment corporation (nasdaq:gain) (the "company") announced today that as a result of the october 14, 2024 federal holiday the company's transfer agent will distribute the payment of the supplemental distribution of $0.70 per share of common stock on tuesday, october 15, 2024. the record date for the supplemental distribution remains unchanged.

THOUGHTWORKS AND AI SINGAPORE JOIN FORCES TO ADVANCE RELIABILITY OF AI AND ITS ADOPTION

News

singapore--(business wire)--twks announced a strategic collaboration with ai singapore to develop novel methods and tools to meaningfully evaluate genai applications.

MAWSON INFRASTRUCTURE GROUP INC. ANNOUNCES MONTHLY OPERATIONAL UPDATE FOR AUGUST 2024

News

digital colocation revenue up 166% y/y from august 2023 and 25% m/m from july 2024 total monthly revenue up 27% m/m from july 2024 expanded into artificial intelligence (ai) and high-performance computing (hpc) colocation business executed ai customer colocation agreement for 20 mw for 6-years to colocate nvidia gpus, expected to generate cumulative revenue potential of $285 million 1 signed ai customer colocation loi for ai and hpc expansion to 144 mw expanded to ohio with 24 mw planned capacity, expected to increase total capacity to 153 mw upon completion midland, pa., sept. 16, 2024 (globe newswire) -- mawson infrastructure group inc. (nasdaq: migi) (“mawson” or “the company”), a publicly-traded technology company focused on digital infrastructure platforms for artificial intelligence (ai), high-performance computing (hpc), and digital assets markets, today announced its unaudited business and operational update for august 2024.

ENLIVEN THERAPEUTICS ANNOUNCES POSITIVE DATA UPDATE FROM PHASE 1 CLINICAL TRIAL OF ELVN-001 IN CHRONIC MYELOID LEUKEMIA

News

updated phase 1 data presented at esh-icmlf 26 th annual john goldman conference reported cumulative mmr rate of 44% (8/18) by 24 weeks, with stable or deepening responses between weeks 12 and 24, which continues to compare favorably to precedent phase 1 trials of approved bcr::abl1 tkis elvn-001 remains well-tolerated with no dose reductions reported with 39 patients enrolled and a median treatment duration of 20 weeks at cutoff boulder, colo., sept. 28, 2024 (globe newswire) -- enliven therapeutics, inc. (enliven or the company) (nasdaq: elvn), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced updated, positive data from the phase 1 clinical trial evaluating elvn-001 in patients with chronic myeloid leukemia (cml) that has failed, or the patient is intolerant to or not a candidate for, available therapies known to be active for treatment of their cml (nct05304377) at the european society of hematology international chronic myeloid leukemia foundation (esh-icmlf) 26th annual john goldman conference.

VERU TO PRESENT AT THE 2024 CANTOR GLOBAL HEALTHCARE CONFERENCE

News

miami, fl, sept. 11, 2024 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced that mitchell steiner, m.d., chairman, president and chief executive officer of veru, will present a corporate update with a focus on the progress of veru's phase 2b clinical development program of enobosarm to augment fat loss and to avoid muscle loss when combined with glp-1 drugs for weight loss at the 2024 cantor global healthcare conference on september 18th at 1:55 pm – 2:25 pm eastern time.

MULTIMEDIA UPDATE -- MICROSOFT AND REZOLVE AI PARTNER TO DRIVE GLOBAL RETAIL INNOVATION WITH AI-POWERED COMMERCE SOLUTIONS

News

redmond, wash. and new york, oct. 03, 2024 (globe newswire) -- microsoft corporation (nasdaq: msft) and rezolve ai (nasdaq: rzlv), a global leader in ai-powered commerce solutions, today announced a strategic partnership to empower retailers with advanced capabilities for digital engagement. through this collaboration, rezolve ai's brain suite – including brain commerce, brain checkout, and brain assistant – will be powered by microsoft azure and available globally via microsoft's azure marketplace and co-sell channels.

DISTRIBUTION SOLUTIONS GROUP'S OPERATING COMPANY, TESTEQUITY, ENTERS INTO AGREEMENT FOR STRATEGIC ACQUISITION

News

fort worth, texas--(business wire)--distribution solutions group, inc. (nasdaq:dsgr) ("dsg" or the "company"), a premier specialty distribution company, today announced that its operating company testequity signed an agreement to acquire conres test equipment, (“conres te”), a division of continental resources, inc. (“conres”), in a carve-out transaction of this leading test and measurement equipment provider based near boston in bedford, massachusetts. “we are thrilled to add a premier suite o.

DLOCAL APPOINTS CARLOS MENENDEZ AS CHIEF OPERATING OFFICER

News

dlocal strengthens leadership team with the appointment of carlos menendez as new coo and ongoing service of jacobo singer as board member following a transition period dlocal strengthens leadership team with the appointment of carlos menendez as new coo and ongoing service of jacobo singer as board member following a transition period

NICKELODEON LETS KIDS' VOICES BE HEARD THIS ELECTION SEASON WITH RETURN OF KIDS PICK THE PRESIDENT "KIDS' VOTE" POLL AND BRAND-NEW SPECIAL

News

nick's "kids' vote" launches today, with results revealed in special hosted by nate burleson and his daughter mia, debuting monday, oct. 28, on nickelodeon platforms and paramount+ share it: @nickelodeon #kidspickthepresident click here  to download asset.

ALT5 ANNOUNCES PLAN TO SEPARATE INTO TWO INDEPENDENT PUBLICLY TRADED COMPANIES

News

las vegas, nv / accesswire / october 2, 2024 / alt5 sigma corporation (nasdaq:alts) ("alt5" or the "company"), a fintech innovator providing next-generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and secure storage of digital assets, has announced a strategic plan to separate into two distinct companies. following consummation of this plan, alt5 will execute the separation of its fintech and biotech businesses, with alt5 continuing as a leading fintech organization post-separation.

APTORUM GROUP LIMITED REPORTS 2023 FISCAL YEAR END FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

News

new york & london--(business wire)--aptorum group limited (nasdaq: apm) (“aptorum group” or “we”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financial results for the fiscal year ended december 31, 2023, and provided an update on corporate developments. mr. ian huen, chief executive officer and executive director of aptorum group, commented, “throughout 2023, we have maintained a.

AMERICA'S CAR-MART, INC. ANNOUNCES APPOINTMENT OF CHIEF OPERATING OFFICER

News

rogers, ark., sept. 24, 2024 (globe newswire) -- america's car-mart, inc. (nasdaq: crmt) (car-mart), one of the largest publicly held automotive retailers in the united states focused exclusively on the “integrated auto sales and finance” segment of the used car market, announced today the appointment of jamie fischer as chief operating officer (coo), effective october 7th, 2024. she will oversee dealership operations and related support functions including inventory management and marketing.

COUCHBASE ANNOUNCES SECOND QUARTER FISCAL 2025 FINANCIAL RESULTS

News

santa clara, calif. , sept. 4, 2024 /prnewswire/ -- couchbase, inc. (nasdaq: base), the cloud database platform company, today announced financial results for its second quarter ended july 31, 2024.

CONSENSUS CLOUD SOLUTIONS, INC. REPORTS FIRST QUARTER 2023 RESULTS

News

los angeles--(business wire)--consensus cloud solutions, inc. (nasdaq: ccsi) today reported preliminary financial results for the first quarter of 2023. first quarter unaudited 2023 highlights q1 2023 gaap quarterly revenues increased by $2.2 million or 2.4% to $91.5 million compared with $89.3 million for q1 2022. our growth was primarily due to an increase of $2.9 million or 6.2% in our corporate business; partially offset by a decline of $0.7 million or 1.8% in our soho business. on a constant dollar basis, revenues grew by $2.7 million or 3.0% over the prior comparable period. gaap net income (1) decreased to $15.5 million in q1 2023 compared to $18.5 million for q1 2022. the decrease is primarily due to increased employee related expenses of $3.2 million, $2.3 million in professional fees in connection with the year-end audit and a $1.0 million noncash foreign exchange impact related to intercompany balances; partially offset by higher revenues. gaap net income per diluted share (1) decreased to $0.78 in q1 2023 compared to $0.92 for q1 2022. the decrease is related to the items discussed above. adjusted ebitda (3)(4) for q1 2023 of $44.2 million is unfavorable compared to q1 2022 adjusted ebitda (3)(4) of $48.6 million. the decrease is related to the items discussed above. adjusted non-gaap earnings per diluted share (1)(2)(3) for the quarter decreased to $1.10 or 17.3% compared to adjusted non-gaap earnings per diluted share (1)(2)(3) of $1.33 for q1 2022. the decrease is related to the items discussed above. consensus ended the quarter with $111.3 million in cash and cash equivalents after cash outlays of $9.2 million in repurchases of common stock and $8.5 million in capital expenditures. key financial results from operations for q1 2023 versus q1 2022 are set forth in the following table. reconciliations of adjusted non-gaap net income, adjusted non-gaap earnings per diluted share and adjusted ebitda to their nearest comparable gaap financial measures accompany this press release. (unaudited, in thousands except per share amounts and percentages) favorable / (unfavorable) q1 2023 q1 2022 change gaap revenues $ 91,454 $ 89,298 2.4 % gaap net income (1) $ 15,458 $ 18,521 (16.5 )% gaap net income per diluted share (1) $ 0.78 $ 0.92 (15.2 )% adjusted non-gaap net income (1)(2) $ 21,993 $ 26,631 (17.4 )% adjusted non-gaap earnings per diluted share (1)(2)(3) $ 1.10 $ 1.33 (17.3 )% adjusted ebitda (3)(4) $ 44,236 $ 48,562 (8.9 )% adjusted ebitda margin (3) 48.4 % 54.4 % (6.0) pts reaffirms 2023 guidance (5) the following table presents ranges for the company’s 2023 full year guidance (in millions, except per share amounts): low midpoint high revenue $ 370 $ 380 $ 390 adjusted ebitda $ 192 $ 199 $ 206 adjusted non-gaap earnings per diluted share (6)(7) $ 4.93 $ 5.08 $ 5.20 va contract update subsequent to the quarter, consensus, cognosante and the department of veterans affairs (“va”) successfully implemented enterprise cloud fax (ecfax) at two locations. notes: (1) the estimated gaap effective tax rates were approximately 24.9% for q1 2023 and 27.5% for q1 2022. the estimated non-gaap effective tax rates were approximately 20.0% for q1 2023 and 20.3% for q1 2022. (2) adjusted non-gaap net income and adjusted non-gaap earnings per diluted share excludes certain non-gaap items, as defined in the accompanying reconciliation of gaap to adjusted non-gaap financial measures, for the three months ended march 31, 2023 and 2022. such exclusions totaled $0.32 and $0.41 per diluted share, respectively. adjusted non-gaap net income and adjusted non-gaap earnings per diluted share are not meant as a substitute for gaap, but are presented solely for informational purposes. (3) adjusted ebitda is defined as earnings before interest; other (income) expense, net; income tax expense; depreciation and amortization; and other items used to reconcile gaap income per diluted share to adjusted non-gaap earnings per diluted share, as presented in the reconciliation of gaap to adjusted non-gaap financial measures. adjusted ebitda amounts are not meant as a substitute for gaap, but is presented solely for informational purposes. (4) see net income to adjusted ebitda reconciliation for the components of consensus adjusted ebitda. (5) full year guidance is provided on a non-gaap basis only because certain information necessary to calculate the most comparable gaap measures is unavailable due to the uncertainty and inherent difficulty of predicting the occurrence and the future financial statement impact of certain items. therefore, as a result of the uncertainty and variability of the nature and amount of future adjustments, which could be significant, we are unable to provide a reconciliation of these measures without unreasonable effort. (6) guidance for adjusted non-gaap earnings per diluted share excludes share-based compensation, amortization of acquired intangibles and the impact of unanticipated items, in each case net of tax. the non-gaap effective tax rate for 2023 is expected to be between 19.7% and 21.7%. (7) guidance for adjusted non-gaap earnings per diluted share range reflects an increase in depreciation and amortization year-over-year resulting from increased capitalized software placed into service between $5 million and $7 million over the prior period. about consensus cloud solutions consensus cloud solutions, inc. (nasdaq: ccsi) is the world’s largest digital fax provider and a trusted global source for the transformation, enhancement and secure exchange of digital information. we leverage our 25-year history of success by providing advanced solutions for regulated industries such as healthcare, finance, insurance and manufacturing, as well as state and the federal government. our solutions consist of: cloud faxing; digital signature; intelligent data extraction using natural language processing and artificial intelligence; robotic process automation; interoperability; and workflow enhancement that result in improved healthcare outcomes. our solutions can be combined with best-in-class managed services for optimal implementations. for more information about consensus, visit consensus.com and follow @consensuscs on twitter to learn more. “safe harbor” statement under the private securities litigation reform act of 1995: certain statements in this press release are “forward-looking statements” within the meaning of the private securities litigation reform act of 1995. these forward-looking statements are based on management’s current expectations or beliefs and are subject to numerous assumptions, risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. these factors and uncertainties include, among other items: the company’s ability to grow fax revenues, profitability and cash flows; the company’s ability to identify, close and successfully transition acquisitions; subscriber growth and retention; variability of the company’s revenue based on changing conditions in particular industries and the economy generally; protection of the company’s proprietary technology or infringement by the company of intellectual property of others; the risk of adverse changes in the u.s. or international regulatory environments, including but not limited to the imposition or increase of taxes or regulatory-related fees; general economic and political conditions, including political tensions and war (such as the ongoing conflict in ukraine); and the numerous other factors set forth in consensus’ filings with the securities and exchange commission (“sec”). for a more detailed description of the risk factors and uncertainties affecting consensus, refer to the 2022 annual report on form 10-k filed by consensus on march 31, 2023, and the other reports filed by consensus from time-to-time with the sec, each of which is available at www.sec.gov. the forward-looking statements provided in this press release are subject to change. although management’s expectations may change after the date of this press release, the company undertakes no obligation to revise or update these statements. about non-gaap financial measures to supplement our consolidated financial statements, which are prepared and presented in accordance with gaap, we use the following adjusted non-gaap financial measures: adjusted non-gaap net income, adjusted non-gaap earnings per diluted share, adjusted ebitda and free cash flow. the presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with gaap. we use these adjusted non-gaap financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. our management believes that these adjusted non-gaap financial measures provide meaningful supplemental information regarding our performance and liquidity by excluding certain expenses and expenditures that may not be indicative of our recurring core business operating results. we believe that both management and investors benefit from referring to these adjusted non-gaap financial measures in assessing our performance and when planning, forecasting, and analyzing future periods. these adjusted non-gaap financial measures also facilitate management’s internal comparisons to our historical performance and liquidity. we believe these adjusted non-gaap financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of our business. for more information on these adjusted non-gaap financial measures, please see the appropriate gaap to adjusted non-gaap reconciliation tables included within the attached exhibit to this release. consensus cloud solutions, inc. and subsidiaries condensed consolidated balance sheets (unaudited, in thousands except share and per share data) march 31, 2023 december 31, 2022 assets cash and cash equivalents $ 111,265 $ 94,164 accounts receivable, net of allowances of $4,727 and $4,681, respectively 29,644 28,029 prepaid expenses and other current assets 14,607 14,335 total current assets 155,516 136,528 property and equipment, net 61,419 54,958 operating lease right-of-use assets 7,459 7,875 intangibles, net 48,096 49,156 goodwill 347,752 346,585 deferred income taxes 36,639 35,981 other assets 6,392 2,816 total assets $ 663,273 $ 633,899 liabilities and stockholders’ deficit accounts payable and accrued expenses $ 54,305 $ 41,246 income taxes payable, current 2,786 2,548 deferred revenue, current 25,336 24,579 operating lease liabilities, current 2,818 2,793 due to former parent 207 156 total current liabilities 85,452 71,322 long-term debt 794,341 793,865 deferred revenue, noncurrent 2,316 2,319 operating lease liabilities, noncurrent 13,379 13,877 liability for uncertain tax positions 7,438 6,725 deferred income taxes 737 728 other long-term liabilities 321 324 total liabilities 903,984 889,160 commitments and contingencies common stock, $0.01 par value. authorized 120,000,000; total issued is 20,118,967 and 20,105,545 shares and total outstanding is 19,659,661 and 19,916,431 shares at march 31, 2023 and december 31, 2022, respectively 201 201 treasury stock, at cost (459,306 and 189,114 shares at march 31, 2023 and december 31, 2022, respectively) (16,791 ) (7,596 ) additional paid-in capital 26,859 21,650 accumulated deficit (234,950 ) (250,408 ) accumulated other comprehensive loss (16,030 ) (19,108 ) total stockholders’ deficit (240,711 ) (255,261 ) total liabilities and stockholders’ deficit $ 663,273 $ 633,899 consensus cloud solutions, inc. and subsidiaries condensed consolidated statements of income (unaudited, in thousands except share and per share data) three months ended march 31, 2023 2022 revenues $ 91,454 $ 89,298 cost of revenues (1) 17,508 15,104 gross profit 73,946 74,194 operating expenses: sales and marketing (1) 16,893 15,830 research, development and engineering (1) 1,904 2,336 general and administrative (1) 21,152 17,369 total operating expenses 39,949 35,535 income from operations 33,997 38,659 interest expense (12,566 ) (13,274 ) other (expense) income, net (844 ) 174 income before income taxes 20,587 25,559 income tax expense 5,129 7,038 net income $ 15,458 $ 18,521 net income per common share: basic $ 0.78 $ 0.93 diluted $ 0.78 $ 0.92 weighted average shares outstanding: basic 19,847,280 19,921,375 diluted 19,884,657 20,035,827 (1) includes share-based compensation expense as follows: cost of revenues $ 296 $ 223 sales and marketing 372 273 research, development and engineering 40 356 general and administrative 4,432 4,551 total $ 5,140 $ 5,403 consensus cloud solutions, inc. and subsidiaries condensed consolidated statements of cash flows (unaudited, in thousands) three months ended march 31, 2023 2022 cash flows from operating activities: net income $ 15,458 $ 18,521 adjustments to reconcile net income to net cash provided by operating activities: depreciation and amortization 4,347 3,706 amortization of financing costs and discounts 495 461 non-cash operating lease costs 416 447 share-based compensation 5,140 5,403 provision for doubtful accounts 1,831 608 deferred income taxes, net (66 ) (1,310 ) changes in operating assets and liabilities: decrease (increase) in: accounts receivable (3,429 ) (3,148 ) prepaid expenses and other current assets (266 ) (494 ) other assets 424 (433 ) increase (decrease) in: accounts payable and accrued expenses 12,400 14,799 income taxes payable 206 4,776 deferred revenue 735 1,886 operating lease liabilities (423 ) (459 ) liability for uncertain tax positions 713 — other liabilities (10 ) 5,145 net cash provided by operating activities 37,971 49,908 cash flows from investing activities: purchases of property and equipment (8,548 ) (6,915 ) acquisition of businesses, net of cash received — (12,855 ) purchase of investments (4,000 ) — purchases of intangible assets — (1,000 ) net cash used in investing activities (12,548 ) (20,770 ) cash flows from financing activities: debt issuance costs — (232 ) repurchase of common stock (9,195 ) — shares withheld related to net share settlement (451 ) (1,173 ) net cash used in financing activities (9,646 ) (1,405 ) effect of exchange rate changes on cash and cash equivalents 1,324 (647 ) net change in cash and cash equivalents 17,101 27,086 cash and cash equivalents at beginning of period 94,164 66,778 cash and cash equivalents at end of period $ 111,265 $ 93,864 consensus cloud solutions, inc. and subsidiaries reconciliation of gaap to adjusted non-gaap financial measures (unaudited, in thousands, except share and per share amounts) the following tables set forth reconciliations regarding certain non-gaap measures for the three months ended march 31, 2023 and 2022 to the most closely comparable gaap measure. three months ended march 31, 2023 per diluted share * 2022 per diluted share * net income $ 15,458 $ 0.78 $ 18,521 $ 0.92 plus: share-based compensation (1) 4,332 0.22 4,911 0.25 amortization (2) 756 0.04 1,150 0.06 spin-off related costs (3) — — 270 0.01 non-income related sales tax (4) 383 0.02 262 0.01 acquisition related integration costs (5) 52 — 102 0.01 accounting fees for tax provision (6) — — 43 — intra-entity transfer (7) 882 0.04 1,372 0.07 sales force realignment (8) 130 0.01 — — adjusted non-gaap net income $ 21,993 $ 1.10 $ 26,631 $ 1.33 * the reconciliation of net income per share from gaap to adjusted non-gaap may not foot since each is calculated independently. non-gaap financial measures to supplement its unaudited consolidated financial statements, the company uses the following non-gaap financial measures: adjusted ebitda, adjusted non-gaap net income and adjusted non-gaap diluted eps (collectively the “non-gaap financial measures”). the presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with u.s. gaap. the company uses these non-gaap financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. the company believes that they provide useful information about core operating results, enhance the overall understanding of past financial performance and future prospects, and allow for greater transparency with respect to key metrics used by management in its financial and operational decision making. (1) share-based compensation. the company excludes stock-based compensation because it is non-cash in nature and because the company believes that the non-gaap financial measures excluding this item provides meaningful supplemental information regarding the operational performance of the business. the company further believes this measure is useful to investors in that it allows for greater transparency to certain line items in its financial statements. in addition, excluding this item from the non-gaap measures facilitates comparisons to historical operating results and comparisons to peers, many of which similarly exclude this item. (2) amortization. the company excludes amortization of patents and acquired intangible assets because it is non-cash in nature and because the company believes that the non-gaap financial measures excluding this item provides meaningful supplemental information regarding the operational performance of the business. in addition, excluding this item from the non-gaap measures facilitates comparisons to historical operating results and comparisons to peers, many of which similarly exclude this item. (3) spin-off related costs. the company excludes certain expenses associated with the spin-off from ziff davis, inc. the company believes that the non-gaap financial measures excluding this item provides meaningful supplemental information regarding the operational performance of the business. in addition, excluding this item from the non-gaap measures facilitates comparisons to historical operating results and comparisons to peers. (4) non-income related sales tax. the company has excluded certain non-income related sales taxes because this expense is related to our historical sales tax exposure in applicable states that have started to tax software as a service (“saas”) in recent years. the company is in the process of remediating the exposure and doesn't believe it will be recurring. as a result, the company believes that the non-gaap financial measures excluding this item provide meaningful supplemental information regarding the operational performance of the business. (5) acquisition related integration costs. the company excludes certain acquisition and related integration costs such as adjustments to contingent consideration, severance, lease terminations, retention bonuses and other acquisition-specific items. the company believes that the non-gaap financial measures excluding this item provide meaningful supplemental information regarding operational performance. in addition, excluding this item from the non-gaap measures facilitates comparisons to historical operating results and comparisons to peers, many of which similarly exclude this item. (6) accounting fees for tax provision. the company excludes certain costs associated with the preparation for the tax provision because these costs are expected to be nonrecurring. the company believes that the non-gaap financial measures excluding this item provides meaningful supplemental information regarding the operational performance of the business. (7) intra-entity transfers. the company excludes certain effects of intra-entity transfers to the extent the related tax asset or liability in the financial statement is not recovered or settled, respectively during the year. during december 2019, the company entered into an intra-entity asset transfer that resulted in the recording of a tax benefit and related tax asset representing tax deductible amounts to be realized in future years which is expected to be recovered over a period of up to 20 years. the company believes that the non-gaap financial measures excluding the cumulative future unrealized benefit of the assets transferred and including the tax benefit in the year of realization provides meaningful supplemental information regarding operational performance. in addition, excluding this item from the non-gaap measures facilitates comparisons to historical operating results. (8) sales force realignment. the company excludes certain business sales force realignment costs such as adjustments to severance and retention bonuses. the company believes that the non-gaap financial measures excluding this item provide meaningful supplemental information regarding operational performance. in addition, excluding this item from the non-gaap measures facilitates comparisons to historical operating results and comparisons to peers, many of which similarly exclude this item. consensus cloud solutions, inc. and subsidiaries net income to adjusted ebitda reconciliation (unaudited, in thousands) the following table sets forth a reconciliation of adjusted ebitda to net income, the most directly comparable gaap financial measure. three months ended march 31, 2023 2022 net income $ 15,458 $ 18,521 plus: interest expense 12,566 13,274 other expense (income), net 844 (174 ) income tax expense 5,129 7,038 depreciation and amortization 4,347 3,706 ebitda: plus: share-based compensation 5,140 5,403 sales force realignment 173 — spin-off related costs — 359 non-income related sales tax 510 241 acquisition related costs 69 136 accounting fees for the tax provision — 58 adjusted ebitda $ 44,236 $ 48,562 adjusted ebitda as calculated above represents earnings before interest, other expense (income), net, income tax and depreciation and amortization and the items used to reconcile gaap to adjusted non-gaap financial measures, including (1) share-based compensation; (2) sales force realignment; (3) spin-off related costs; (4) non-income related sales tax; (5) acquisition related costs; and (6) accounting fees for the tax provision. we disclose adjusted ebitda as a supplemental non-gaap financial performance measure as we believe it is a useful metric by which to compare the performance of our business from period to period. we understand that measures similar to adjusted ebitda are broadly used by analysts, rating agencies and investors in assessing our performance. accordingly, we believe that the presentation of adjusted ebitda provides useful information to investors. adjusted ebitda is not in accordance with, or an alternative to, net income, and may be different from non-gaap measures used by other companies. in addition, adjusted ebitda is not based on any comprehensive set of accounting rules or principles. this adjusted non-gaap measure has limitations in that it does not reflect all of the amounts associated with the company’s results of operations determined in accordance with gaap. consensus cloud solutions, inc. and subsidiaries non-gaap financial measures (unaudited, in thousands) q1 q2 (2) q3 q4 (2) ytd 2023 net cash provided by operating activities (1) $ 37,971 $ — $ — $ — $ 37,971 less: purchases of property and equipment (8,548 ) — — — (8,548 ) free cash flows $ 29,423 $ — $ — $ — $ 29,423 q1 q2 (2) q3 q4 (2) ytd 2022 net cash provided by operating activities (1) $ 49,908 $ 2,298 $ 37,066 $ (6,123 ) $ 83,149 less: purchases of property and equipment (6,915 ) (6,829 ) (7,316 ) (8,985 ) (30,045 ) free cash flows $ 42,993 $ (4,531 ) $ 29,750 $ (15,108 ) $ 53,104 (1) the decline in net cash provided by operating activities when compared to q1 2022 is primarily related to delayed payments of $9.7 million ($4.6 million in taxes payable and $5.1 million in other liabilities - representing balances due to ziff davis) in the prior period absent a similar build in the current period and current period voluntary disclosure agreements (“vda”) payments of $3.4 million. (2) net cash provided by operating activities during the second quarter and fourth quarter was impacted by cash outlays related to interest expense payments of approximately $26 million (occurring in q2 and q4) and other significant payments. the company discloses free cash flows as supplemental non-gaap financial performance measure, as it believes it is a useful metric by which to compare the performance of its business from period to period. the company also understands that this non-gaap measure is broadly used by analysts, rating agencies and investors in assessing the company’s performance. accordingly, the company believes that the presentation of this non-gaap financial measure provides useful information to investors. free cash flows is not in accordance with, or an alternative to, cash flows from operating activities, and may be different from non-gaap measures with similar or even identical names used by other companies. in addition, the non-gaap measure is not based on any comprehensive set of accounting rules or principles. this non-gaap measure has limitations in that it does not reflect all of the amounts associated with the company’s results of operations determined in accordance with gaap. key performance metrics (unaudited) the following table sets forth certain key operating metrics for consensus for the three months ended march 31, 2023 and 2022 (in thousands, except for percentages): three months ended march 31, 2023 2022 corporate revenue $ 49,407 $ 46,519 corporate customer accounts (1) 53 46 corporate arpa (2) $ 315.76 $ 339.95 corporate paid adds (3) 3 4 corporate monthly account churn (4) 1.37 % 2.05 % soho revenue $ 42,030 $ 42,779 soho customer accounts (1) 914 1,027 soho arpa (2) $ 15.10 $ 13.88 soho paid adds (3) 78 100 soho monthly account churn (4) 3.76 % 3.50 % (1) consensus customers are defined as paying corporate and soho customer accounts. (2) represents a monthly arpa for the quarter or year calculated as follows. monthly arpa on a quarterly basis is calculated using our standard convention of dividing revenue for the quarter by the average of the quarter’s beginning and ending customer base and dividing that amount by 3 months. consensus believes arpa provides investors an understanding of the average monthly revenues we recognize per account associated within consensus’ customer base. as arpa varies based on fixed subscription fee and variable usage components, consensus believes it can serve as a measure by which investors can evaluate trends in the types of services, levels of services and the usage levels of those services across consensus’ customers. (3) paid adds represents paying new consensus customer accounts added during the annual period. (4) monthly churn is defined as a consensus paying customer accounts that cancelled its services during the period divided by the average number customers over the period. this measure is calculated monthly and expressed as an average over the applicable period.

LUXURBAN HOTELS INC. REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

News

miami, florida, september 25, 2024 – prism mediawire – luxurban hotels inc. (nasdaq: luxh), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today announced its financial results for the second quarter ended june 30, 2024 (“q2 2024”).

CALAVO GROWERS, INC. ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS, DIVIDEND INCREASE

News

santa paula, calif., sept. 09, 2024 (globe newswire) -- calavo growers, inc. (nasdaq-gs: cvgw), a global leader in the processing and distribution of avocados, tomatoes, papayas, and guacamole, today reported its financial results for the fiscal third quarter ended july 31, 2024.

AUTOZI INTERNET TECHNOLOGY (GLOBAL) LTD. ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING

News

beijing , aug. 29, 2024 /prnewswire/ -- autozi internet technology (global) ltd. ("autozi" or the "company") (nasdaqgm: azi), one of the leading and fast-growing lifecycle automotive service providers in china, today announced the closing of its initial public offering (the "offering") of 2,500,000 class a ordinary shares at a public offering price of us$4 per class a ordinary share.

INSTEEL INDUSTRIES ANNOUNCES FOURTH QUARTER 2024 CONFERENCE CALL

News

mount airy, n.c.--(business wire)--insteel industries inc. (nyse: iiin) today announced that its fourth quarter 2024 earnings conference call will be webcast live over the internet on thursday, october 17, 2024 at 10:00 a.m. et following the release of the company's fourth quarter financial results at 6:30 a.m. et on that same day. the conference call can be accessed on the company's website at https://investor.insteel.com and will be archived for replay. about insteel insteel is the nation's l.

VERACYTE TO PARTICIPATE IN THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE

News

south san francisco, calif.--(business wire)--veracyte, inc. (nasdaq: vcyt) announced today that marc stapley, chief executive officer, and rebecca chambers, chief financial officer, will participate in a fireside chat at the morgan stanley 22nd annual global healthcare conference on thursday, september 5, at 2:35 p.m. eastern time. a live audio webcast of the company's presentation will be available by visiting veracyte's website at http://investor.veracyte.com/events-presentations. a replay o.

RAPT THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

south san francisco, calif., may 09, 2024 (globe newswire) -- rapt therapeutics, inc. (nasdaq: rapt), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today reported financial results for the first quarter ended march 31, 2024.

MICROVAST AND MINESPIDER TO SHOW BATTERY PASSPORT DEMO AT IAA TRANSPORTATION 2024

News

stafford, texas & hannover, germany--(business wire)--microvast holdings, inc. (nasdaq: mvst) (“microvast” or the “company”), a technology innovator that designs, develops and manufactures lithium-ion battery solutions, and minespider, a technology company offering battery passports compliant with the eu battery regulation, today announced that together they will show a battery passport demo for the first time at iaa transportation 2024. the event will take place in hannover, germany from septe.

AUDIOEYE ACQUIRES ADA SITE COMPLIANCE, A DIGITAL ACCESSIBILITY COMPLIANCE COMPANY

News

announces accretive acquisition of ada site compliance and increases revenue and adjusted ebitda guidance tucson, ariz. , sept. 30, 2024 /prnewswire/ --  audioeye, inc. (nasdaq: aeye) ("audioeye" or the "company"), the industry-leading digital accessibility company, today announced it has acquired ada site compliance, an ada website accessibility compliance solution that provides audits and best practices to help organizations create websites that are accessible and compliant to wcag standards.

CENTRUS TO PARTICIPATE IN TD COWEN'S 2024 NUCLEAR FUEL & NEXT GENERATION ROUNDTABLE

News

bethesda, md. , sept. 30, 2024 /prnewswire/ -- centrus energy corp. (nyse american: leu) today announced that management are scheduled to participate in td cowen's 2024 nuclear fuel & next generation virtual roundtable on october 8.

WEARABLE DEVICES EXPANDS ITS INTERNATIONAL IP PORTFOLIO WITH FILED PATENT APPLICATION FOR NEURAL WRIST TECHNOLOGY IN SOUTH KOREA

News

the new patent application, filed as part of the patent cooperation treaty (pct) national stage, aims to protect the company's global patent portfolio in the asian markets

COSTAMARE INC. ANNOUNCES ELECTION OF CLASS II DIRECTORS AT 2024 ANNUAL MEETING OF STOCKHOLDERS

News

monaco, oct. 03, 2024 (globe newswire) -- costamare inc. (the “company”) (nyse: cmre), an international owner and provider of containerships and dry bulk vessels for charter, announced the election of two class ii directors at the company's virtual annual meeting of stockholders held today.